News at Smith

Nov 30, 2015
World Class Faculty & Research

With double-digit annual GDP growth and the world's largest population, China until recently looked like the long-term answer for U.S. companies seeking never-ending growth. With its slowdown and concurrent stock-market turmoil, China is posing fresh challenges, says Anil K. Gupta, the Michael D. Dingman Chair in Strategy, Globalization and Entrepreneurship at the University of Maryland's Robert H. Smith School of Business. Growing uncertainty in China, moreover, may lead some companies to move more aggressively into India, whose

Nov 24, 2015
World Class Faculty & Research

​The Robert H. Smith School of Business is partnering with the Office of Financial Research on a  challenge for research teams to link four disparate financial datasets.

Nov 23, 2015
Community

Smith student Philip Peker ’18 writes about the annual Future Women in Business Conference at the University of Maryland’s Robert H. Smith School of Business.  On Friday, Nov. 20, 2015, local high school women visited Smith to learn about careers in business.

Nov 20, 2015
World Class Faculty & Research

Here's good news if you're looking for discounts, bad news if you're in the retail industry: Third quarter 2015 was brutal for much of the retail sector. For analysts, the mystery is why few people used the windfall from low gas prices to splurge on themselves or their families. In expectation of such spending, retailers let their inventories rise, a decision some now regret.

Nov 20, 2015
World Class Faculty & Research

Martin Shkreli became the Internet villain of the fall (some publications used much harsher language) when his company, Turing Pharmaceuticals, acquired the rights to Daraprim, which treats a condition called toxoplasmosis — and promptly raised the per-pill price from $13.50 to $750. The move was entirely legal, but a bipartisan U.S. Senate committee is looking into what one senator called "price gouging" in the industry.

Pages

Subscribe to News